Interpace Biosciences, Inc. (IDXG)
6.20
+0.15
(+2.48%)
USD |
OTCM |
Nov 16, 16:00
Interpace Biosciences Price : 6.20 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 6.08 | 6.20 | 6.08 | 6.20 | 1429.00 |
| Nov 13, 2026 | 6.146 | 6.146 | 6.05 | 6.05 | 441.00 |
| Nov 12, 2026 | 6.20 | 6.25 | 6.20 | 6.20 | 1802.00 |
| Nov 11, 2026 | 6.60 | 6.60 | 6.60 | 6.60 | 121.00 |
| Nov 10, 2026 | 7.00 | 7.00 | 7.00 | 7.00 | 0.000 |
| Nov 09, 2026 | 7.00 | 7.00 | 7.00 | 7.00 | 14.00 |
| Nov 06, 2026 | 6.06 | 7.00 | 6.06 | 7.00 | 305.00 |
| Nov 05, 2026 | 5.74 | 7.45 | 5.74 | 7.00 | 2110.00 |
| Nov 04, 2026 | 5.462 | 5.72 | 5.452 | 5.72 | 2462.00 |
| Nov 03, 2026 | 5.442 | 5.442 | 5.442 | 5.442 | 99.00 |
| Nov 02, 2026 | 5.442 | 5.442 | 5.442 | 5.442 | 204.00 |
| Oct 30, 2026 | 5.592 | 5.592 | 5.592 | 5.592 | 502.00 |
| Oct 29, 2026 | 5.126 | 5.72 | 5.05 | 5.72 | 5107.00 |
| Oct 28, 2026 | 5.45 | 5.45 | 4.95 | 4.95 | 1880.00 |
| Oct 27, 2026 | 5.50 | 5.50 | 5.50 | 5.50 | 1.000 |
| Oct 26, 2026 | 6.00 | 6.00 | 5.50 | 5.50 | 3314.00 |
| Oct 23, 2026 | 5.80 | 6.50 | 5.80 | 6.50 | 2753.00 |
| Oct 22, 2026 | 5.40 | 5.40 | 5.40 | 5.40 | 124.00 |
| Oct 21, 2026 | 5.25 | 5.25 | 5.05 | 5.05 | 1163.00 |
| Oct 20, 2026 | 5.10 | 5.30 | 5.10 | 5.30 | 1255.00 |
| Oct 19, 2026 | 5.09 | 5.819 | 5.00 | 5.00 | 7128.00 |
| Oct 16, 2026 | 5.20 | 5.20 | 5.05 | 5.15 | 1752.00 |
| Oct 15, 2026 | 5.38 | 5.39 | 5.27 | 5.27 | 3267.00 |
| Oct 14, 2026 | 5.518 | 5.518 | 5.518 | 5.518 | 261.00 |
| Oct 13, 2026 | 6.072 | 6.13 | 5.90 | 5.90 | 3747.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exlites Holdings International, Inc. | 0.35 |
| Xcelerate, Inc. | 0.0219 |
| Vivos Therapeutics, Inc. | 0.0802 |
| Hinge Health, Inc. | 114.51 |
| PD-Rx Pharmaceuticals, Inc. | 3.10 |
Price Related Metrics
| PE Ratio | 1.405 |
| PS Ratio | 0.9505 |
| PEG Ratio | 0.0323 |
| Price to Book Value | 1.478 |
| Price to Free Cash Flow | 8.371 |
| Earnings Yield | 71.16% |
| Market Cap | 34.35M |
| PEGY Ratio | 0.0323 |
| Operating PE Ratio | 8.246 |
| Normalized PE Ratio | 1.41 |